Insect stings.
Recently, significant gains have been made in the care of the patient allergic to stinging insects. Though epinephrine continues to be the drug of choice for the management of the anaphylactic reaction, newer delivery systems allow self-administration of the drug immediately following a sting to abort or attenuate a subsequent reaction. Patients most at risk, those with a history of life-threatening episodes of anaphylaxis following a sting, can be diagnosed and treated with the recently released Hymenoptera venoms with the expectation of excellent results. This success, however, has been accompanied by the frustration of not knowing the natural course of the disease in sufficient detail to counsel in cases of less dramatic insect hypersensitivity.